In the wake of the recent financial crisis, over-the-counter (OTC) derivatives have been blamed for increasing systemic risk. Although OTC derivatives were not a central cause of the crisis, the complexity and limited transparency of the market reinforced the potential for excessive risk-taking, as regulators did not have a clear view into how OTC derivatives were being used. We discuss how the New York Fed and other regulators could improve weaknesses in the OTC derivatives market through stronger oversight and better regulatory incentives for infrastructure improvements to reduce counterparty credit risk and bolster market liquidity, efficiency, and transparency. Used responsibly with these reforms, over-the-counter derivatives can provide important risk management and liquidity benefits to the financial system.

More on this topic

BFI Working Paper·Aug 4, 2026

Two Selection Problems, One Bias Term: Experimental Sign-Up Is Treatment Choice in Disguise

John List
Topics: Uncategorized
BFI Working Paper·Jun 23, 2026

Misleading Estimates from Nonlinear Models with a Binary Outcome

Brian Curran, Bruce Meyer, and Derek Wu
Topics: Uncategorized
BFI Working Paper·Jun 15, 2026

Don’t Give Up on Lab Experiments: Why the Field Still Needs the Lab

John List
Topics: Uncategorized